COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Masataka Nishiga(Cardiovascular Institute of the South), Joseph C. Wu(Cardiovascular Institute of the South)

Nature Reviews Cardiology

July 20, 2020

10.1038/s41569-020-0413-9

Cited by 1,463

Related Papers

A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy

|Cell|2016|257

Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes

|Cell stem cell|2020|232

Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome

|Cell stem cell|2020|171

Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging

|Nature Medicine|2024|156

A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay

|Circulation|2019|124